Eton and Aquestive announce exclusive licensing for LIBERVANT, a buccal film for seizure clusters, launching April 2027 ...

EXCLUSIVE: Barbera Thornhill has been accused of having an infamous "Mar-a-Lago" makeover after a picture of her was released ...

Differentiated, portable buccal film would offer patients and caregivers an alternative to existing nasal and rectal seizure rescue treatments, a ...

(OTCQB:HEPA) ("Hepion" or the "Company"), a biotechnology company developing a portfolio of diagnostic and therapeutic candidates for serious liver, immune, and inflammatory diseases, today announced ...

Aquestive Therapeutics is upgraded to a Buy, anticipating Anaphylm approval and potential >$250m annual revenue by 2030. Click to read more on AQST.

Hepion Pharmaceuticals completes the Gravitas Life Sciences acquisition, creating a three-program portfolio across therapeutics and diagnostics.

Four Chicago-area protesters say their DNA was unlawfully taken by DHS agents outside the Broadview ICE Detention Center. The government has moved to dismiss their case, one that a new Georgetown Law ...

Under the agreement, Eton will obtain exclusive rights to commercialize LIBERVANT in the United States and its territories, while Aquestive will continue to manufacture and supply the product. Eton ...

The allowance advances the intellectual-property foundation behind InsuTab™, Insu's investigational buccal insulin formulation, and BuccaGLP™, its investigational buccal semaglutide formulation. Both ...

EXCLUSIVE: Several women in President Donald Trump's inner circle have been criticized for undergoing the so-called ...

A randomized crossover trial found that zastaprazan’s orally disintegrating tablet delivers equivalent blood exposure with or ...

A national Italian study of 82 long-term care facilities found that nearly one in four solid oral medications is altered before administration and that more than a third of these manipulations are ...